Extracted data included title, trial name, the first author, publication year, country/region, dose, administration route, median follow-up time, sample size, age, sex, race, body mass index (BMI), smoke, blood pressure, glycated hemoglobin (HbA1c), T2DM duration, estimated glomerular filtration rate (eGFR), baseline CVD or CKD, and measures of effect assessed by the hazard ratio (HR) and its 95% confidence interval (CI) for each of the cardiovascular outcomes
Supports Metabolism and Fat Loss Increases Fat Metabolism: IGF-1 LR3 can promote the breakdown of body fat by supporting metabolic processes, making it easier for women to manage weight and reduce visceral fat around organs
The follow-up duration ranged from 28 to 40 months, with an average duration of 34 months
Esto significa que, adems de disminuir la sensacin de hambre, los mimticos de GLP-1 pueden reducir el deseo compulsivo de comer (conocido comnmente como antojos) y la tendencia a comer por razones emocionales o psicolgicas, y no solo por necesidad fsica